Topics:

Nervous System Diseases

Amyotrophic Lateral Sclerosis in a Young Man

The neurodegeneration of ALS is relentlessly progressive and presently incurable. Only one medication has been shown to extend life. Here, a case study, including videos.

Nervous System Diseases

A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.

There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.

While a majority of persons with the 4 most common cancers are told the diagnosis, fewer than half of persons with AD get that kind of information. This could be a problem.

An FDA-approved drug for high blood pressure alleviates clinical symptoms of MS in mice, showing great promise for humans.

Focused ultrasound works like a noninvasive knife, cutting away amyloid plaques in mice. But is this new method safe and effective in humans?

Could Alzheimer Disease be Type 3 Diabetes

Evidence is mounting that links insulin deficiency and insulin resistance to mediation of Alzheimer disease-type neurodegeneration. Get the highlights in these 9 slides.

Noninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.

Pages

Subscribe to Nervous System Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.